Literature DB >> 25914485

Clinical literature review of 1858 Crohn's disease cases requiring surgery in China.

Qing-Hai Peng1, Yu-Fang Wang1, Man-Qing He1, Cui Zhang1, Qin Tang1.   

Abstract

AIM: To summarize the clinical characteristics of Crohn's disease (CD) patients who underwent surgery in China.
METHODS: We searched four main Chinese electronic databases: CBM, VIP, CNKI, and Wanfang (from January 1990 to October 2013). Then, we selected and carefully read 97 studies and extracted the surgical data for CD. We found that 1858 patients with CD underwent surgery between 1961 and 2012. The patients were stratified into two groups according to the year of surgery: 1961-2000 and 2000-2012. The clinical characteristics of these CD cases were compared between the two groups.
RESULTS: The mean age at the time of surgery was 38.13 years. The most common locations of disease were the small intestine (40.84%), the colon (33.60%) and the ileocolon (23.09%). The primary indications for surgery were intestinal obstruction or stricture (23.84%), failure of drug therapy (14.80%), acute abdominal disease (13.46%), abdominal mass (10.93%), intestinal fistulae (9.90%), intestinal perforation (8.45%), perianal disease (6.73%), gastrointestinal bleeding (4.79%), and abdominal abscess (4.04%). The rate of diagnosis of CD before surgery was low (34.78%), and the misdiagnosis rate was 20.49%. The predominant surgical procedure for CD was bowel resection (69.54%). The rate of surgical complications was 20.34%, and the primary complications of surgery were infection (39.44%) and intestinal fistulae (26.09%). The relapse rate after surgery was 27.71%. For the periods of 1961-2000 and 2000-2013, the rates of both misdiagnosis before surgery and surgery related-death decreased (34.90% vs 12.10%, P < 0.001, and 23.53% vs 5.26%, P < 0.001, respectively).
CONCLUSION: The rates of surgical complications and misdiagnosis were higher, whereas the rate of CD-associated tumor and the relapse rate were lower in China than in West countries.

Entities:  

Keywords:  Crohn’s disease; Surgery; Surgical complications; Surgical indications; Surgical recurrence

Mesh:

Year:  2015        PMID: 25914485      PMCID: PMC4402323          DOI: 10.3748/wjg.v21.i15.4735

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 2.  Differential diagnosis between Crohn's disease and intestinal tuberculosis in China.

Authors:  Z Y Zhou; H S Luo
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

4.  Long-term clinical results of ileocecal resection for Crohn's disease.

Authors:  Garret Cullen; Aoibhlinn O'toole; Denise Keegan; Kieran Sheahan; John M Hyland; Diarmuid P O'donoghue
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

5.  Indications for laparoscopic surgery for Crohn's disease using the Vienna Classification.

Authors:  K Okabayashi; H Hasegawa; M Watanabe; H Nishibori; Y Ishii; T Hibi; M Kitajima
Journal:  Colorectal Dis       Date:  2007-07-20       Impact factor: 3.788

6.  Risk factors and indications for first surgery in Crohn's disease patients.

Authors:  Naofumi Morimoto; Jun Kato; Motoaki Kuriyama; Tsuyoshi Fujimoto; Junichirou Nasu; Jiro Miyaike; Takechiyo Morita; Hiroyuki Okada; Seiyuu Suzuki; Junji Shiode; Hiroshi Yamamoto; Kohsaku Sakaguchi; Yasushi Shiratori
Journal:  Hepatogastroenterology       Date:  2007 Oct-Nov

Review 7.  Short-term outcomes after laparoscopic ileocolic resection for Crohn's disease. A systematic review.

Authors:  Sebastiaan W Polle; Jan Wind; Dirk T Ubbink; Daan W Hommes; Dirk J Gouma; Willem A Bemelman
Journal:  Dig Surg       Date:  2006-12-12       Impact factor: 2.588

8.  Clinical manifestations of inflammatory bowel disease: East and West differences.

Authors:  Yu Fang Wang; Hu Zhang; Qin Ouyang
Journal:  J Dig Dis       Date:  2007-08       Impact factor: 2.325

Review 9.  Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis.

Authors:  D Epstein; G Watermeyer; R Kirsch
Journal:  Aliment Pharmacol Ther       Date:  2007-06-15       Impact factor: 8.171

10.  Early versus late surgery for ileo-caecal Crohn's disease.

Authors:  A Aratari; C Papi; G Leandro; A Viscido; L Capurso; R Caprilli
Journal:  Aliment Pharmacol Ther       Date:  2007-09-10       Impact factor: 8.171

View more
  6 in total

1.  Outcome of Surgery for Coloduodenal Fistula in Crohn's Disease.

Authors:  Jianfeng Gong; Yao Wei; Lili Gu; Yi Li; Zhen Guo; Jing Sun; Chao Ding; Weiming Zhu; Ning Li; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2015-12-30       Impact factor: 3.452

Review 2.  WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.

Authors:  Belinda De Simone; Justin Davies; Elie Chouillard; Salomone Di Saverio; Frank Hoentjen; Antonio Tarasconi; Massimo Sartelli; Walter L Biffl; Luca Ansaloni; Federico Coccolini; Massimo Chiarugi; Nicola De'Angelis; Ernest E Moore; Yoram Kluger; Fikri Abu-Zidan; Boris Sakakushev; Raul Coimbra; Valerio Celentano; Imtiaz Wani; Tadeja Pintar; Gabriele Sganga; Isidoro Di Carlo; Dario Tartaglia; Manos Pikoulis; Maurizio Cardi; Marc A De Moya; Ari Leppaniemi; Andrew Kirkpatrick; Vanni Agnoletti; Gilberto Poggioli; Paolo Carcoforo; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-05-11       Impact factor: 5.469

3.  Severe contiguous perianal Crohn's disease.

Authors:  Tricie K Toledo; Helena R Camasmie; Carlos A F Athayde; Ricardo B Lima; Antonio M D'Acri; Carlos J Martins; Omar Lupi
Journal:  JAAD Case Rep       Date:  2016-03-21

4.  Effect of Loureirin B on Crohn's disease rat model induced by TNBS via IL-6/STAT3/NF-κB signaling pathway.

Authors:  Xueliang Sun; Ke Wen; Zhizhong Xu; Zongqi He; Bensheng Wu; Xiao Yang; Xiaopeng Wang
Journal:  Chin Med       Date:  2020-01-06       Impact factor: 5.455

5.  A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes.

Authors:  Debora Garza-Hernandez; Maricruz Sepulveda-Villegas; Jose Garcia-Pelaez; Raul Aguirre-Gamboa; Peter L Lakatos; Karol Estrada; Manuel Martinez-Vazquez; Victor Trevino
Journal:  BMC Genomics       Date:  2022-04-13       Impact factor: 3.969

Review 6.  Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectives.

Authors:  James P Campbell; Byron P Vaughn
Journal:  Clin Exp Gastroenterol       Date:  2016-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.